Glaucoma Drop Aids Part 2

Launched by BOSTON MEDICAL CENTER · Jan 29, 2025

Keywords

ClinConnect Summary

This clinical trial, called "Glaucoma Drop Aids Part 2," is looking at a special device called the Nanodropper, which might help patients with glaucoma take their eye drops more easily. Glaucoma is a condition that can cause vision loss, and using eye drops regularly is very important to manage it. Researchers at Boston Medical Center have noticed that many patients struggle to use their eye drop bottles correctly, either because they have trouble seeing or can't squeeze the bottles properly. This can lead to wasting the medication and not getting the full benefit. The goal of this study is to see if the Nanodropper can help these patients use their drops more effectively.

To participate in this trial, you need to be a patient at Boston University Eye Associates and have been using the same glaucoma eye drops for at least two months. Unfortunately, if you've changed your medication in the last two months, you wouldn't be eligible. If you join the study, you can expect to use the Nanodropper and see if it makes taking your medication easier, which could help you manage your glaucoma better and protect your vision. The trial is not yet recruiting participants, but it could provide valuable insight into how to improve eye drop use for patients with glaucoma.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Currently on the same topical ophthalmic medications for treatment of glaucoma for a minimum of two months
• • Patient of Boston University Eye Associates
• Exclusion Criteria:
• • Changed glaucoma medications within the past 2 months